Best Peptides for Cognitive Function Research

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone, modified for metabolic stability. Research has focused on its effect on brain-derived neurotrophic factor (BDNF) and nerve growth factor signaling, with studies proposing it activates a transcription pathway that drives neurotrophin gene expression.

Selank is a synthetic heptapeptide derived from tuftsin, developed in Russia as a candidate anti-anxiety compound. It's studied as a positive modulator of GABA-A receptors, enhancing GABA binding at a site distinct from the benzodiazepine binding site —the proposed basis for anxiety-reducing activity without benzodiazepine-type sedation.

Dihexa is a peptidomimetic derived from angiotensin IV, studied preclinically as an allosteric modulator that promotes dimerization of hepatocyte growth factor (HGF), enhancing signaling through its receptor c-Met. HGF/c-Met signaling in the hippocampus and cortex is linked to synapse formation, the basis for studying dihexa in cognitive-function models.

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by Vladimir Khavinson's research group, studied in laboratory models for neuroprotective effects, including suppression of reactive-oxygen-species accumulation and modulation of apoptosis-related signaling in neural cells.

DSIP (Delta Sleep-Inducing Peptide) is a short neuropeptide first isolated from rabbit brain in the 1970s during research into the neurochemistry of slow-wave sleep, and has since been studied as a possible modulator of sleep architecture, stress hormones, and pain signaling.

Adamax is marketed by research-peptide suppliers as a modified analog of Semax, with an adamantane group added to the backbone to improve resistance to enzymatic breakdown and blood-brain-barrier penetration. The rationale draws on Semax's own study history in neurotrophic and cognitive research.